BioSpace News Archive

Panbela Therapeutics, Inc. announced that management will participate in a panel discussion titled, “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 2022, at 12:00 pm ET.

Heat Biologics, Inc. announces the appointment of Greg Burel, former Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response Director of the Strategic National Stockpile, to the Company’s Biothreat Advisory Board and as a senior advisor to the Company.

Nova Mentis Life Science Corp. is proud to announce that it has begun the patient enrollment process for its North American Observational study: Establishing a Diagnostic and Therapeutic Index in Autism Spectrum Disorder and Fragile X Syndrome.

Flanders Investment and Trade is a Flemish government organization that facilitates investment projects in Flanders, a northern region of Belgium, and supports Flemish companies.

MedX Health Corp., a global leader in teledermatology, is pleased to announce that Naman Demaghlatrous has been appointed as the Company’s President and Chief Executive Officer, effective immediately.

Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration (NMPA), commonly referred to as China FDA, approval for its unique cyclically pressurized Topical Wound Oxygen (TWO2) therapy.

PacBio, a leading developer of high-quality, highly accurate, sequencing platforms, announced the company’s expansion to better serve customers in the Europe, Middle East and Africa region.

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that The University of Texas at Austin has granted Vaxxas an exclusive license to a next-generation SARS-CoV-2 spike subunit vaccine (HexaPro), for vaccination using a patch.

Medical Database, Inc., an innovative provider of clinical laboratory and medical content, today announced the successful integration of its cutting-edge laboratory decision system, LDS®, with Epic.

Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, provides the following letter to its shareholders from CEO Greg Siokas: